Herbas VPB

Print
EN | LT
LT - Riluzolo provaisto naudojimas ataksijų gydymui
EN - USE OF RILUZOLE PRODRUGS TO TREAT ATAXIAS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/428 (2006.01)
A61K 31/427 (2006.01)
A61K 31/4985 (2006.01)
A61P 35/00 (2006.01)
C07D 277/82 (2006.01)
C07D 417/12 (2006.01)
A61K 9/48 (2006.01)
A61K 9/20 (2006.01)
A61P 25/14 (2006.01)
European patent
(11) Number of the document 3706739
(13) Kind of document T
(96) European patent application number 18876779.2
Date of filing the European patent application 2018-11-11
(97) Date of publication of the European application 2020-09-16
(45) Date of publication and mention of the grant of the patent 2024-10-16
(46) Date of publication of the claims translation 2024-12-27
PCT application
(86) Number PCT/US2018/060232
Date 2018-11-11
PCT application publication
(87) Number WO 2019/094851
Date 2019-05-16
Priority applications
(30) Number Date Country code
201762584856 P 2017-11-12 US
201862717948 P 2018-08-13 US
Inventors
(72)
CORIC, Vladimir , US
BERMAN, Robert , US
BEINER, Melissa , US
L'ITALIEN, Gilbert , US
Grantee
(73) Biohaven Therapeutics Ltd. , 215 Church Street, New Haven, CT 06510, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Riluzolo provaisto naudojimas ataksijų gydymui
  USE OF RILUZOLE PRODRUGS TO TREAT ATAXIAS
Last renewal fee
Payment date Validity (years) Amount
2024-11-07 7 162.00 EUR
Next renewal fee
2025-11-11